Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse laplace transform (FILT)

  • Yoshitaka Yano
  • Kiyoshi Yamaoka
  • Yoshihiro Aoyama
  • Hisashi Tanaka


A dispersion model developed in Chromatographic theory is applied to the analysis of the elution profile in the liver perfusion system of experimental animals. The equation for the dispersion model with the linear nonequilibrium partition between the perfusate and an organ tissue is derived in the Laplace-transformed form, and the fast inverse Laplace transform (FILT) is introduced to the pharmacokinetic field for the manipulation of the transformed equation. By the analysis of the nonlinear least squares method associated with FILT, this model (two-compartment dispersion model) is compared to the model with equilibrium partition between the perfusate and the liver tissue (one-compartment dispersion model) for the outflow curves of ampicillin and oxacillin from the rat liver. The model estimation by Akaike's information criterion (AIC) suggests that the two-compartment dispersion model is more proper than the one-compartment dispersion model to mathematically describe the local disposition of these drugs in the perfusion system. The blood space in the liver, VB, and the dispersion number DN are estimated at 1.30 ml (±0.23 SD) and 0.051 (±0.023 SD), respectively, both of which are independent of the drugs. The efficiency number, RN, of ampicillin is 0.044 (±0.049 SD) which is significantly smaller than 0.704 (±0.101 SD) of oxacillin. The parameters in the two-compartment dispersion model are correlated to the recovery ratio, FH, mean transit time, ¯tH, and the relative variance, σ2/¯tH2, of the elution profile of drugs from the rat liver.

Key words

AIC rat liver perfusion FILT MULTI (FILT) one-compartment dispersion model two-compartment dispersion model ampicillin oxacillin 



Cross-sectional area of the blood space

C(t, z)

Concentration of drug (one-compartment dispersion model)

∼C(s, z)

Laplace transform of C(t, z)

C1(t, z)

Concentration of drug in blood space (two-compartment dispersion model)

C2(t, z)

Concentration of drug in the liver tissue (two-compartment dispersion model)

∼C1 (s, z)

Laplace transform ofC1(t, z)


Axial or longitudinal dispersion coefficient

Dc(=D· A2)

Corrected dispersion coefficient


Dispersion number


Input function with respect tot


Input function with respect toz


Laplace transform of fI(t)


System weight function with respect tot


System weight function with respect to z


Recovery ratio


Partition ratio (distribution ratio)

k12, k21

Forward and backward partition rate constant in the central elimination two-compartment dispersion model


Forward and backward partition rate constant in the peripheral elimination two-compartment dispersion model


Elimination (or irreversible transfer) rate constant


Elimination rate constant in peripheral elimination model


Distribution constant


Length of blood space in liver


Amount of drug injected


Coefficient related to the injected amount


Mass transfer coefficient from perfusate to hepatic tissue


Flow rate of perfusate


Efficiency number


Laplace variable



¯ tH

Mean transit time


Linear flow velocity of the perfusate

VB(= L·A)

Blood volume (sum of the sinusoid volume and the space of Disse)


Apparent volume of distribution


Anatomical volume of liver tissue


Axial coordinate in the liver


Delta function


Volume ratio of the anatomical liver tissue to the blood space


Variance of transit time


Relative dispersion to transit time

Partial derivatives


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    K. S. Pang and M. Rowland. Hepatic clearance of drugs: 1. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J. Pharmacokin. Biopharm. 5:625–653 (1977).CrossRefGoogle Scholar
  2. 2.
    G. R. Wilkinson and D. G. Shand. Commentary. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).PubMedGoogle Scholar
  3. 3.
    M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharmacokin. Biopharm. 1:123–136 (1977).CrossRefGoogle Scholar
  4. 4.
    L. Bass, S. Keiding, K. Winkler, and N. Tygstrup. Enzymatic elimination of substrates flowing through the intact liver.J. Theor. Biol. 61:393–409 (1976).PubMedCrossRefGoogle Scholar
  5. 5.
    R. W. Brauer, G. F. Leong, P. F. McElory, Jr., and R. J. Holloway. Circulatory pathways in the rat liver as revealed by32P chromic phosphate colloid uptake in the isolated perfused liver preparation.Am. J. Physiol. 184:593–598 (1956).PubMedGoogle Scholar
  6. 6.
    M. Weiss. Moment of physiological transit time distribution and the time course of drug disposition in the body.J. Math. Biol. 15:305–318 (1982).PubMedCrossRefGoogle Scholar
  7. 7.
    L. Bass, P. Robinson, and A. J. Bracken. Hepatic elimination of flowing substrates: the distributed model.J. Theor. Biol. 72:161–184 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    E. L. Forker and B. Luxton. Hepatic transport kinetic and plasma disappearance curves: Distributed modeling versus conventional approach.Am. J. Physiol. 235:E648-E660 (1978).PubMedGoogle Scholar
  9. 9.
    C. A. Goresky, W. H. Ziegler, and G. G. Bach. Capillary exchange modeling. Barrier-limited and flow limited distribution.Circ. Res. 27:739–764 (1970).PubMedCrossRefGoogle Scholar
  10. 10.
    M. S. Roberts and M. Rowland. Hepatic elimination: dispersion model.J. Pharm. Sci. 74:585–587 (1985).PubMedCrossRefGoogle Scholar
  11. 11.
    M. S. Roberts and M. Rowland. A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.J. Pharmacokin. Biopharm. 14:227–260 (1986).CrossRefGoogle Scholar
  12. 12.
    L. Lapidus and N. R. Amundson. Mathematics of adsorption in beds. VI. The effect of longitudinal diffusion in ion exchange and Chromatographic columns.J. Phys. Chem. 56:984–988 (1952).CrossRefGoogle Scholar
  13. 13.
    K. Yamaoka, and T. Nakagawa. Moment analysis for reaction chromatography.J. Chromatog. 117:1–10 (1976).CrossRefGoogle Scholar
  14. 14.
    T. Hosono. Numerical inversion of Laplace transform and some applications to wave optics. Radio Sci.16:1015–1019 (1981).CrossRefGoogle Scholar
  15. 15.
    K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer.J. Pharmacobio-Dyn. 4:879–885 (1981).PubMedCrossRefGoogle Scholar
  16. 16.
    A. B. Littlewood.Gas Chromatography, Academic Press, New York, 1970, pp. 164–232.CrossRefGoogle Scholar
  17. 17.
    O. Levenspiel.Chemical Reaction Engineering, Wiley, New York, 1972, pp. 235–315.Google Scholar
  18. 18.
    C. A. Goresky and G. G. Bach. Membrane transport and the hepatic circulation.Ann. N.Y. Acad. Sci. 170 (1):18–47 (1970).CrossRefGoogle Scholar
  19. 19.
    K. Yamaoka, T. Nakagawa, and T. Uno. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.J. Pharmacokin. Biopharm. 6:165–175 (1978).CrossRefGoogle Scholar
  20. 20.
    M. Barza and L. Weinstein. Pharmacokinetics of the penicillins in man.Clin. Pharmacokin. 1:297–308 (1976).CrossRefGoogle Scholar
  21. 21.
    Y. Murai, T. Nakagawa, K. Yamaoka, and T. Uno. High performance liquid Chromatographic analysis and pharmacokinetic investigation of oxacillin and its metabolites in man.Chem. Pharm. Bull. 29:3290–3297 (1981).PubMedCrossRefGoogle Scholar
  22. 22.
    C. A. Goresky. A linear method for determining liver sinusoidal and extravascular volumes.Am. J. Physiol. 204:626–640 (1963).PubMedGoogle Scholar
  23. 23.
    W. Perl and F. P. Chinard. A convection-diffusion model of indicator transport through an organ.Circ. Res. 22:273–298 (1967).CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Yoshitaka Yano
    • 1
  • Kiyoshi Yamaoka
    • 1
  • Yoshihiro Aoyama
    • 1
  • Hisashi Tanaka
    • 1
  1. 1.Faculty of Pharmaceutical SciencesKyoto UniversityKyotoJapan

Personalised recommendations